使用LIGHT增强CAR T细胞功能
Winson Cai1,2, Kento Tanaka3, Xiaoli Mi3
1Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Cancer immunology research
|July 3, 2024
概括
化学抗原受体 (CAR) T细胞疗法在固体瘤中表现有前途,通过设计CAR T细胞来表达LIGHT. 这增强了瘤细胞的杀死,并可能防止抗原阴性疾病的复发.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞疗法细胞疗法
背景情况:
- 化学抗原受体 (CAR) T细胞治疗对B细胞癌症有效,但由于向抗原异质性,在固体瘤中面临挑战.
- 在固体瘤治疗中,抗原逃逸和复发仍然是CAR T细胞治疗的重大障碍.
研究的目的:
- 开发一种新的CAR T细胞策略,以克服固体瘤中的抗原异质性.
- 通过结合LIGHT介导,抗原独立的瘤细胞杀死来增强CAR T细胞的疗效.
主要方法:
- 工程CAR T细胞过度表达LIGHT,一种与癌细胞上的淋巴毒素-β受体 (LTBR) 和免疫细胞上的疹病毒进入介质 (HVEM) 相互作用的配体.
- 评估了工程CAR T细胞的双机制细胞毒性 (CAR介导和LIGHT介导) 和免疫刺激性质.
主要成果:
- 光表达的CAR-T细胞表现出CAR-依赖的,抗原特异性杀死以及对瘤细胞的光依赖的,抗原独立的细胞毒性.
- 在经过工程改造以表达LIGHT的CAR T细胞中观察到增强的增殖和改善的细胞解剖特征.
- 双重作用的CAR T细胞显示出消除抗原阴性瘤细胞的潜力,解决了复发的关键原因.
结论:
- 光表达的CAR T细胞提供了一种有前途的策略,以克服固体瘤中的抗原异质性.
- 这种方法提高了CAR T细胞的持续性和有效性,可能防止疾病复发.
- 轻工设计的CAR T细胞代表了固体瘤免疫疗法的潜在进步.
相关概念视频
01:27Tumor Immunotherapy
509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509
01:22T Cell Activation and Clonal Selection
697
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
697
01:24T Cell Types and Functions
996
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
996